Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure

Table 2 Mean score of the KCCQ-12 in 118 patients with primary prevention ICD due to heart failure

KCCQ-12	All n = 118 Mean score	Ischemic HF n = 69 Mean score	Nonischemic HF n = 49 Mean score	Ischemic versus nonischemic HF p value
Physical limitation	68.0 ± 26.4	64.6 ± 26.2	72.8 ± 26.1	0.062
Symptom frequency	78.6 ± 21.1	77.2 ± 21.5	80.6 ± 20.5	0.305
Quality of life	69.7 ± 25.7	68.8 ± 25.7	70.9 ± 25.8	0.582
Social limitation	71.6 ± 27.0	68.8 ± 27.1	75.6 ± 26.7	0.144
Overall summary score	71.5 ± 22.4	69.5 ± 23.1	74.4 ± 21.3	0.195

KCCQ-12	All n = 118 Mean score	ICD-VR/DR n = 61 Mean score	CRT-D n = 57 Mean score	ICD-VR/DR versus CRT-D p value
Physical limitation	68.0 ± 26.4	72.0 ± 23.3	63.7 ± 28.9	0.158
Symptom frequency	78.6 ± 21.1	82.3 ± 20.5	74.8 ± 21.2	0.040
Quality of life	69.7 ± 25.7	73.2 ± 25.2	66.0 ± 25.9	0.093
Social limitation	71.6 ± 27.0	75.0 ± 27.5	68.0 ± 26.3	0.096
Overall summary score	71.5 ± 22.4	75.1 ± 22.0	67.7 ± 22.4	0.041

Statistically significant p-values are given in bold
Comparisons are made between ischemic versus nonischemic HF and VR/DR versus CRTD
CRT-D cardiac resynchronization therapy defibrillator, HF heart failure, ICD implantable cardioverter defibrillator, ICD-VR/DR single or dual lead implantable cardioverter defibrillator, KCCQ-12 12-item Kansas City Cardiomyopathy Questionnaire, SD standard deviation

ISSN: 1471-2261